Lori Ellis Head of Insights | Biospace
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Nordic biotech leaders discuss strategies for global competitiveness

Industry professionals discussed the future of Nordic biotechnology in a recent episode of Denatured, released on July 23. The conversation featured Ester Sklarsky, principal at Sound Bioventures, and João Ribas, partner at Novo Holdings Seed Investments. The discussion focused on the diverse development paths within the Nordic biotech sector and explored what steps are needed for countries such as Norway and Finland to collaborate more effectively and compete internationally.

The episode was hosted by Jennifer C. Smith-Parker, Director of Insights at BioSpace. Sklarsky and Ribas shared their perspectives on regional challenges and opportunities within the industry.

During the conversation, both guests addressed how fragmentation has affected growth in Nordic biotech and considered potential solutions to unify efforts across borders.

A disclaimer stated that "the views expressed in this discussion by guests are their own and do not represent those of their organizations." No further details about specific policy recommendations or upcoming initiatives were provided during this episode.

Organizations in this story

More News